Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



GOED on new cancer study: ‘Results do not support a change in omega-3 intake’

By Stephen Daniells , 14-Feb-2014
Last updated on 05-Mar-2014 at 15:47 GMT2014-03-05T15:47:36Z

GOED on new cancer study: ‘Results do not support a change in omega-3 intake’

A new study that links omega-3 intakes and an increased risk of endometrial cancer changes nothing for current recommendations for omega-3s, says the Global Organization for EPA and DHA Omega-3s (GOED).

Epidemiological data published in the American Journal of Clinical Nutrition by Theodore Brasky and his team from The Ohio State University suggested that there was an association between high omega-3 intakes and an increased risk of endometrial cancer in overweight and obese women.

On the other hand, increased intakes of omega-3s for normal-weight women were associated with statistically significant reductions in cancer risk, said the researchers.

The only other study examining specific omega-3 intakes and endometrial cancer was performed by Hannah Arem et al. from Yale School of Public Health, which found that high intakes of omega-3s may reduce the risk of this particular cancer (European Journal of Nutrition , 2013, Vol. 52, pp. 1251-60. doi: 10.1007/s00394-012-0436-z).

However, other studies examining fish intake and endometrial cancer have found a positive association.

Commenting on the study’s findings, Harry Rice, PhD, V.P., Regulatory & Scientific Affairs for GOED, told us: “While results from this study may provide a reason to conduct further research at some point in time, they do not support a change (increase or decrease) in omega-3 intake.”

That prostate cancer study

The study’s findings may attract attention since the authors, Brasky et al., were also involved in last year’s controversial prostate cancer study. That study has been widely debated in omega-3 circles, with many taking exception to the conclusions.

Indeed, the prostate cancer study, which was published in the Journal of the National Cancer Institute (doi: 10.1093/jnci/djt174 ), was also epidemiological and again showed correlation and not causation. It also only measured blood levels of omega-3s and did not consider any differences between fish and supplements. Despite this, co-author Dr Alan Kristal from Fred Hutchinson Cancer Research Center, USA, stated : “We've shown once again that use of nutritional supplements may be harmful.”

Endometrial study

For the new study, Dr Brasky and his co-workers examined intakes of long-chain omega-3s, including EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in 22,494 women aged between 50 and 76 living in Washington State. Intakes from the diet and supplements were assessed using a semi-quantitative food-frequency questionnaire (FFQ).

Over nine years of data collection, there were 263 cases of endometrial cancers documented.

Results showed that women with the highest average dietary intakes of EPA + DHA (over 256 mg per day) had a 79% increased risk of endometrial cancer, compared to women with the lowest average intakes (less than 60 mg per day). Further number crunching showed that the increases in risk were restricted to overweight and obese women, whereas statistically significant reductions in risk were observed for normal-weight women.

“When supplemental exposures were considered in addition to diet, the findings were similar,” added Dr Brasky and his co-authors.

“In this large prospective study, we found that intake of long-chain omega-3 PUFAs and their food sources are positively associated with endometrial cancer risk among overweight and obese women,” they wrote. “In normal-weight women, long-chain omega-3 fatty acids may provide some benefit.

“Because this is an observational study, replication in randomized trials is necessary to confirm these findings. One such study, the ongoing VITamin D and Omega-3 TriAL (VITAL), may be helpful in verifying the results we report here.”

Source: American Journal of Clinical Nutrition
Published online ahead of print, doi:10.3945/ajcn.113.070524
“Associations of long-chain omega-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort”
Authors: Theodore M Brasky, Marian L Neuhouser, David E Cohn, and Emily White

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars